Mid Range AED II
Anti-epileptic 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Felbamate | 50 | µg/mL | 25 days |
Gabapentin | 10 | µg/mL | 25 days |
Lacosamide | 5 | µg/mL | 25 days |
Lamotrigine | 5 | µg/mL | 25 days |
Levetiracetam | 15 | µg/mL | 25 days |
Oxcarbazepine | 2 | µg/mL | 25 days |
10-OH-Carbazepine | 20 | µg/mL | 25 days |
Pregabalin | 5 | µg/mL | 25 days |
Rufinamide | 5 | µg/mL | 25 days |
Tiagabine | 80 | µg/mL | 25 days |
Topiramate | 15 | µg/mL | 25 days |
Zonisamide | 20 | µg/mL | 25 days |
High Range AED II
Anti-epileptic 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Felbamate | 100 | µg/mL | 25 days |
Gabapentin | 40 | µg/mL | 25 days |
Lacosamide | 20 | µg/mL | 25 days |
Lamotrigine | 20 | µg/mL | 25 days |
Levetiracetam | 40 | µg/mL | 25 days |
Oxcarbazepine | 10 | µg/mL | 25 days |
10-OH-Carbazepine | 60 | µg/mL | 25 days |
Pregabalin | 15 | µg/mL | 25 days |
Rufinamide | 40 | µg/mL | 25 days |
Tiagabine | 140 | µg/mL | 25 days |
Topiramate | 50 | µg/mL | 25 days |
Zonisamide | 60 | µg/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Caspofungin | 1.5 | µg/mL | 25 days |
Fluconazole | 4 | µg/mL | 25 days |
5-Flucytosine | 30 | µg/mL | 25 days |
Itraconazole | 1.5 | µg/mL | 25 days |
*Hydroxy-Itraconazole | 1.5 | µg/mL | 25 days |
Posaconazole | 1.5 | µg/mL | 25 days |
Voriconazole | 1.5 | µg/mL | 25 days |
Antifungals Level 2
100% Real Human Matrix Serum Antifungals Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Caspofungin | 9 | µg/mL | 25 days |
Fluconazole | 20 | µg/mL | 25 days |
5-Flucytosine | 65 | µg/mL | 25 days |
Itraconazole | 5 | µg/mL | 25 days |
*Hydroxy-Itraconazole | 5 | µg/mL | 25 days |
Posaconazole | 5 | µg/mL | 25 days |
Voriconazole | 5 | µg/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 0 | ng/mL | 30 days |
d-Methamphetamine | 0 | ng/mL | 30 days |
Benzoylecgonine | 0 | ng/mL | 30 days |
Morphine | 0 | ng/mL | 30 days |
Oxazepam | 0 | ng/mL | 30 days |
Phencyclidine (PCP) | 0 | ng/mL | 30 days |
Secobarbital | 0 | ng/mL | 30 days |
(l)-9-Carboxy-11-nor-Delta-9-THC | 0 | ng/mL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Aripiprazole | 100 | ng/mL | 25 days |
Clozapine | 100 | ng/mL | 25 days |
Desmethylclozapine | 100 | ng/mL | 25 days |
Haloperidol | 10 | ng/mL | 25 days |
Reduced Haloperidol | 10 | ng/mL | 25 days |
Olanzapine | 50 | ng/mL | 25 days |
Quetiapine | 100 | ng/mL | 25 days |
Risperidone | 50 | ng/mL | 25 days |
9-Hydroxyrisperidone | 50 | ng/mL | 25 days |
Ziprasidone | 50 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Aripiprazole | 400 | ng/mL | 25 days |
Clozapine | 400 | ng/mL | 25 days |
Desmethylclozapine | 400 | ng/mL | 25 days |
Haloperidol | 50 | ng/mL | 25 days |
Reduced Haloperidol | 50 | ng/mL | 25 days |
Olanzapine | 100 | ng/mL | 25 days |
Quetiapine | 400 | ng/mL | 25 days |
Risperidone | 150 | ng/mL | 25 days |
9-Hydroxyrisperidone | 150 | ng/mL | 25 days |
Ziprasidone | 150 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Androstenedione | 1.5 | ng/mL | 25 days |
Hydrocortisone (Cortisol) | 6.0 | µg/dL | 25 days |
Cortisone | 1.5 | µg/dL | 25 days |
Corticosterone | 300 | ng/dL | 25 days |
11-Deoxycortisol | 100 | ng/dL | 25 days |
Dehydroepiandrosterone (DHEA) | 3 | ng/mL | 25 days |
Progesterone | 7.5 | ng/mL | 25 days |
17α-Hydroxyprogesterone | 300 | ng/dL | 25 days |
Testosterone | 300 | ng/dL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Androstenedione | 4 | ng/mL | 25 days |
Hydrocortisone (Cortisol) | 20 | µg/dL | 25 days |
Cortisone | 4 | µg/dL | 25 days |
Corticosterone | 800 | ng/dL | 25 days |
11-Deoxycortisol | 300 | ng/dL | 25 days |
Dehydroepiandrosterone (DHEA) | 8 | ng/mL | 25 days |
Progesterone | 20 | ng/mL | 25 days |
17α-Hydroxyprogesterone | 800 | ng/dL | 25 days |
Testosterone | 800 | ng/dL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Methotrexate | 0.05 | µmol/L | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Methotrexate | 0.075 | µmol/L | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Methotrexate | 0.5 | µmol/L | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Methotrexate | 0.75 | µmol/L | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Methylmalonic Acid (MMA) | 0.2 | µmol/L | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Methylmalonic Acid (MMA) | 1.0 | µmol/L | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Pentobarbital | 20 | µg/mL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Bupropion | 70 | ng/mL | n/a |
Citalopram | 70 | ng/mL | 25 |
Duloxetine | 150 | ng/mL | 25 |
Fluoxetine | 150 | ng/mL | 25 |
Norfluoxetine | 150 | ng/mL | 25 |
Fluvoxamine | 100 | ng/mL | 25 |
Paroxetine | 100 | ng/mL | 25 |
Sertraline | 100 | ng/mL | 25 |
Desmethylsertraline | 100 | ng/mL | 25 |
Venlafaxine | 100 | ng/mL | 25 |
Desmethylvenlafaxine | 100 | ng/mL | 25 |
High Range SSRI 7 Plus
100% Real Human Matrix Serum SSRI Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Bupropion | 150 | ng/mL | n/a |
Citalopram | 150 | ng/mL | 25 |
Duloxetine | 600 | ng/mL | 25 |
Fluoxetine | 600 | ng/mL | 25 |
Norfluoxetine | 600 | ng/mL | 25 |
Fluvoxamine | 1,000 | ng/mL | 25 |
Paroxetine | 300 | ng/mL | 25 |
Sertraline | 300 | ng/mL | 25 |
Desmethylsertraline | 300 | ng/mL | 25 |
Venlafaxine | 500 | ng/mL | 25 |
Desmethylvenlafaxine | 500 | ng/mL | 25 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Androstenedione | 0.5 | ng/mL | 25 days |
Hydrocortisone (Cortisol) | 2.5 | µg/dL | 25 days |
Cortisone | 0.6 | µg/dL | 25 days |
Corticosterone | 100 | µg/dL | 25 days |
11-Deoxycortisol | 40 | ng/dL | 25 days |
Dehydroepiandrosterone (DHEA) | 1.0 | ng/mL | 25 days |
Progesterone | 2.5 | ng/mL | 25 days |
17α-Hydroxyprogesterone | 100 | ng/dL | 25 days |
Testosterone | 100 | ng/dL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Androstenedione | 1.0 | ng/mL | 25 days |
Hydrocortisone (Cortisol) | 5.0 | µg/dL | 25 days |
Cortisone | 1.2 | µg/dL | 25 days |
Corticosterone | 200 | ng/dL | 25 days |
11-Deoxycortisol | 80 | ng/dL | 25 days |
Dehydroepiandrosterone (DHEA) | 2.0 | ng/mL | 25 days |
Progesterone | 5.0 | ng/mL | 25 days |
17α-Hydroxyprogesterone | 200 | ng/dL | 25 days |
Testosterone | 200 | ng/dL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Androstenedione | 2.5 | ng/mL | 25 days |
Hydrocortisone (Cortisol) | 12.5 | µg/dL | 25 days |
Cortisone | 3 | µg/dL | 25 days |
Corticosterone | 500 | ng/dL | 25 days |
11-Deoxycortisol | 200 | ng/dL | 25 days |
Dehydroepiandrosterone (DHEA) | 5 | ng/mL | 25 days |
Progesterone | 12.5 | ng/mL | 25 days |
17α-Hydroxyprogesterone | 500 | ng/dL | 25 days |
Testosterone | 500 | ng/dL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Androstenedione | 5 | ng/mL | 25 days |
Hydrocortisone (Cortisol) | 25 | µg/dL | 25 days |
Cortisone | 6 | µg/dL | 25 days |
Corticosterone | 1,000 | ng/dL | 25 days |
11-Deoxycortisol | 400 | ng/dL | 25 days |
Dehydroepiandrosterone (DHEA) | 10 | ng/mL | 25 days |
Progesterone | 25 | ng/mL | 25 days |
17α-Hydroxyprogesterone | 1,000 | ng/dL | 25 days |
Testosterone | 1,000 | ng/dL | 25 days |
Mid Range Tricyclic Antidepressants VI
100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Amitriptyline | 100 | ng/mL | 30 days |
Doxepin | 100 | ng/mL | 30 days |
N-Desmethyldoxepin | 100 | ng/mL | 30 days |
Imipramine | 100 | ng/mL | 30 days |
Desipramine | 100 | ng/mL | 30 days |
Nortriptyline | 100 | ng/mL | 30 days |
High Range Tricyclic Antidepressants VI
100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Amitriptyline | 400 | ng/mL | 30 days |
Doxepin | 400 | ng/mL | 30 days |
N-Desmethyldoxepin | 400 | ng/mL | 30 days |
Imipramine | 400 | ng/mL | 30 days |
Desipramine | 400 | ng/mL | 30 days |
Nortriptyline | 400 | ng/mL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
25-Hydroxy Vitamin D2 (25-OH-D2) | 10 | ng/mL | 25 days |
25-Hydroxy Vitamin D3 (25-OH-D3) | 10 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
25-Hydroxy Vitamin D2 (25-OH-D2) | 30 | ng/mL | 25 days |
25-Hydroxy Vitamin D3 (25-OH-D3) | 30 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
25-Hydroxy Vitamin D2 (25-OH-D2) | 73 | ng/mL | 25 days |
25-Hydroxy Vitamin D3 (25-OH-D3) | 73 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Retinol (Vitamin A) | 450 | ng/mL | 25 days |
Retinyl Palmitate (Vitamin A) New> | 50 | ng/mL | 25 days |
α-Tocopherol (Vitamin E) | 6 | µg/mL | 25 days |
γ-Tocopherol (Vitamin E) New> | 2 | µg/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Retinol (Vitamin A) | 1,500 | ng/mL | 25 days |
Retinyl Palmitate New> | 150 | ng/mL | 25 days |
α-Tocopherol (Vitamin E) | 30 | µg/mL | 25 days |
γ-Tocopherol (Vitamin E) New> | 4.5 | µg/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Acetone | 80 | mg/dL | 30 days |
Ethanol | 150 | mg/dL | 30 days |
Ethylene Glycol | 80 | mg/dL | 30 days |
Isopropanol | 80 | mg/dL | 30 days |
Methanol | 40 | mg/dL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Alprazolam | 37.5 | ng/mL | 25 |
Amobarbital | 90 | ng/mL | 25 |
d-Amphetamine | 11.25 | ng/mL | 25 |
d-Methamphetamine | 11.25 | ng/mL | 25 |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 11.25 | ng/mL | 25 |
Buprenorphine | 6 | ng/mL | 14 |
Butalbital | 90 | ng/mL | 25 |
Carisoprodol | 90 | ng/mL | 25 |
Cocaine | 6 | ng/mL | 25 |
Benzoylecgonine | 6 | ng/mL | 25 |
Codeine | 11.25 | ng/mL | 25 |
Diazepam | 37.5 | ng/mL | 25 |
Ethanol | 75 | mg/dL | 25 |
Fentanyl | 6 | ng/mL | 25 |
Hydrocodone | 11.25 | ng/mL | 25 |
Hydromorphone | 11.25 | ng/mL | 25 |
Lorazepam | 37.5 | ng/mL | 25 |
Methadone | 37.5 | ng/mL | 25 |
Morphine | 11.25 | ng/mL | 25 |
6-Monoacetylmorphine (6-MAM) | 1.5 | ng/mL | 25 |
Oxazepam | 37.5 | ng/mL | 25 |
Oxycodone | 11.25 | ng/mL | 25 |
Oxymorphone | 11.25 | ng/mL | 25 |
Pentobarbital | 90 | ng/mL | 25 |
Phencyclidine (PCP) | 1.5 | ng/mL | 25 |
Phenobarbital | 90 | ng/mL | 25 |
Propoxyphene | 37.5 | ng/mL | 25 |
Secobarbital | 90 | ng/mL | 25 |
Tapentadol | 37.5 | ng/mL | 25 |
Temazepam | 37.5 | ng/mL | 25 |
Tramadol | 37.5 | ng/mL | 25 |
Zolpidem | 37.5 | ng/mL | 25 |
(-)-Delta-9-THC | 1.5 | ng/mL | 14 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Alprazolam | 62.5 | ng/mL | 25 |
Amobarbital | 150 | ng/mL | 25 |
d-Amphetamine | 18.75 | ng/mL | 25 |
d-Methamphetamine | 18.75 | ng/mL | 25 |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 18.75 | ng/mL | 25 |
Buprenorphine | 10 | ng/mL | 14 |
Butalbital | 150 | ng/mL | 25 |
Carisoprodol | 150 | ng/mL | 25 |
Cocaine | 10 | ng/mL | 25 |
Benzoylecgonine | 10 | ng/mL | 25 |
Codeine | 18.75 | ng/mL | 25 |
Diazepam | 62.5 | ng/mL | 25 |
Ethanol | 125 | mg/dL | 25 |
Fentanyl | 10 | ng/mL | 25 |
Hydrocodone | 18.75 | ng/mL | 25 |
Hydromorphone | 18.75 | ng/mL | 25 |
Lorazepam | 62.5 | ng/mL | 25 |
Methadone | 62.5 | ng/mL | 25 |
Morphine | 18.75 | ng/mL | 25 |
6-Monoacetylmorphine (6-MAM) | 2.5 | ng/mL | 25 |
Oxazepam | 62.5 | ng/mL | 25 |
Oxycodone | 18.75 | ng/mL | 25 |
Oxymorphone | 18.75 | ng/mL | 25 |
Pentobarbital | 150 | ng/mL | 25 |
Phencyclidine (PCP) | 2.5 | ng/mL | 25 |
Phenobarbital | 150 | ng/mL | 25 |
Propoxyphene | 62.5 | ng/mL | 25 |
Secobarbital | 150 | ng/mL | 25 |
Tapentadol | 62.5 | ng/mL | 25 |
Temazepam | 62.5 | ng/mL | 25 |
Tramadol | 62.5 | ng/mL | 25 |
Zolpidem | 62.5 | ng/mL | 25 |
(-)-Delta-9-THC | 2.5 | ng/mL | 14 |
DOA (Drugs of Abuse) 50% Cutoff
Cannabinoid SMx (Specialty Matrix) SMx Oral Fluid Drugs of Abuse
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 25 | ng/mL | 25 days |
d-Methamphetamine | 25 | ng/mL | 25 days |
Benzoylecgonine (BE) | 10 | ng/mL | 25 days |
Methadone | 2.5 | ng/mL | 25 days |
Morphine | 20 | ng/mL | 25 days |
Oxazepam | 25 | ng/mL | 25 days |
Phencyclidine (PCP) | 5 | ng/mL | 25 days |
Propoxyphene | 20 | ng/mL | 25 days |
Secobarbital | 15 | ng/mL | 25 days |
Delta-9-THC | 2 | ng/mL | 14 days |
DOA (Drugs of Abuse) Cutoff
Cannabinoid SMx (Specialty Matrix) SMx Oral Fluid Drugs of Abuse
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 50 | ng/mL | 25 days |
d-Methamphetamine | 50 | ng/mL | 25 days |
Benzoylecgonine (BE) | 20 | ng/mL | 25 days |
Methadone | 5 | ng/mL | 25 days |
Morphine | 40 | ng/mL | 25 days |
Oxazepam | 50 | ng/mL | 25 days |
Phencyclidine (PCP) | 10 | ng/mL | 25 days |
Propoxyphene | 40 | ng/mL | 25 days |
Secobarbital | 30 | ng/mL | 25 days |
Delta-9-THC | 4 | ng/mL | 14 days |
DOA (Drugs of Abuse) 200% Cutoff
Cannabinoid SMx (Specialty Matrix) SMx Oral Fluid Drugs of Abuse
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 100 | ng/mL | 25 days |
d-Methamphetamine | 100 | ng/mL | 25 days |
Benzoylecgonine (BE) | 40 | ng/mL | 25 days |
Methadone | 10 | ng/mL | 25 days |
Morphine | 80 | ng/mL | 25 days |
Oxazepam | 100 | ng/mL | 25 days |
Phencyclidine (PCP) | 20 | ng/mL | 25 days |
Propoxyphene | 80 | ng/mL | 25 days |
Secobarbital | 60 | ng/mL | 25 days |
Delta-9-THC | 8 | ng/mL | 14 days |
Benzodiazepines Plus 100 ng/mL
Benzodiazepines 100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Alprazolam | 100 | ng/mL | 25 days |
α-Hydroxyalprazolam | 100 | ng/mL | 25 days |
Chlordiazepoxide | 100 | ng/mL | 25 days |
Clobazam | 100 | ng/mL | 25 days |
Clonazepam | 100 | ng/mL | 25 days |
7-Aminoclonazepam | 100 | ng/mL | n/a |
Diazepam | 100 | ng/mL | 25 days |
Nordiazepam | 100 | ng/mL | 25 days |
Estazolam | 100 | ng/mL | 25 days |
Flunitrazepam | 100 | ng/mL | 25 days |
7-Aminoflunitrazepam | 100 | ng/mL | n/a |
Flurazepam | 100 | ng/mL | 25 days |
Desalkylflurazepam | 100 | ng/mL | 25 days |
Hydroxyethylflurazepam | 100 | ng/mL | 25 days |
Lorazepam | 100 | ng/mL | 25 days |
Midazolam | 100 | ng/mL | 25 days |
Nitrazepam | 100 | ng/mL | 25 days |
7-Aminonitrazepam | 100 | ng/mL | n/a |
Oxazepam | 100 | ng/mL | 25 days |
Temazepam | 100 | ng/mL | 25 days |
Triazolam | 100 | ng/mL | 25 days |
α-Hydroxytriazolam | 100 | ng/mL | 25 days |
Zolpidem | 100 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 100 | ng/mL | 30 days |
(±)-3,4-Methylenedioxyamphetamine (MDA) | 100 | ng/mL | 30 days |
d-Methamphetamine | 100 | ng/mL | 30 days |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 100 | ng/mL | 30 days |
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 100 | ng/mL | 30 days |
Cocaine | 100 | ng/mL | 30 days |
Benzoylecgonine | 100 | ng/mL | 30 days |
Cocaethylene | 100 | ng/mL | 30 days |
Codeine | 100 | ng/mL | 30 days |
Hydrocodone | 100 | ng/mL | 30 days |
Morphine | 100 | ng/mL | 30 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 500 | ng/mL | 30 days |
(±)-3,4-Methylenedioxyamphetamine (MDA) | 500 | ng/mL | 30 days |
d-Methamphetamine | 500 | ng/mL | 30 days |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 500 | ng/mL | 30 days |
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 500 | ng/mL | 30 days |
Cocaine | 500 | ng/mL | 30 days |
Benzoylecgonine (BE) | 500 | ng/mL | 30 days |
Cocaethylene | 500 | ng/mL | 30 days |
Codeine | 500 | ng/mL | 30 days |
Hydrocodone | 500 | ng/mL | 30 days |
Morphine | 500 | ng/mL | 30 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | xx | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Ethanol | 80 | mg/dL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
4-ANPP | 2 | ng/mL | 25 |
Acetylfentanyl | 2 | ng/mL | 25 |
Acrylfentanyl | 2 | ng/mL | 25 |
Alfentanil | 2 | ng/mL | 25 |
Butyryl Fentanyl | 2 | ng/mL | 25 |
Carfentanyl | 2 | ng/mL | 25 |
cis-3-Methylfentanyl | 2 | ng/mL | 25 |
Crotonylfentanyl | 2 | ng/mL | 25 |
Fentanyl | 2 | ng/mL | 25 |
Furanyl Fentanyl | 2 | ng/mL | 25 |
Isobutyrylfentanyl | 2 | ng/mL | 25 |
m-Methylmethoxyacetylfentanyl | 2 | ng/mL | 25 |
Methoxyacetylfentanyl | 2 | ng/mL | 25 |
Norfentanyl | 2 | ng/mL | 25 |
Ocfentanyl | 2 | ng/mL | 25 |
ortho-Fluorofentanyl | 2 | ng/mL | 25 |
para-Fluorobutyrylfentanyl | 2 | ng/mL | 25 |
para-Fluoroisobutyrylfentanyl | 2 | ng/mL | 25 |
para-Fluorofentanyl | 2 | ng/mL | 25 |
Sufentanil | 2 | ng/mL | 25 |
Tetrahydrofuran Fentanyl | 2 | ng/mL | 25 |
U-47700 | 2 | ng/mL | 25 |
U-49900 | 2 | ng/mL | 25 |
U51754 | 2 | ng/mL | 25 |
Valerylfentanyl | 2 | ng/mL | 25 |
Cyclopropylfentanyl | 2 | ng/mL | 25 |
Immunosuppressants Level 1 (3mL)
100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cyclosporine | 90 | ng/mL | 30 days |
Everolimus | 4 | ng/mL | 25 days |
Sirolimus | 4 | ng/mL | 25 days |
Tacrolimus | 4 | ng/mL | 25 days |
Immunosuppressants Level 2 (3mL)
Immunosuppressants 100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cyclosporine | 500 | ng/mL | 30 days |
Everolimus | 15 | ng/mL | 25 days |
Sirolimus | 15 | ng/mL | 25 days |
Tacrolimus | 15 | ng/mL | 25 days |
Immunosuppressants Level 3 (3mL)
Immunosuppressants 100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cyclosporine | 1,200 | ng/mL | 30 days |
Everolimus | 25 | ng/mL | 25 days |
Sirolimus | 25 | ng/mL | 25 days |
Tacrolimus | 25 | ng/mL | 25 days |
Pain Management 100 (PM 100)
100% Real Human Matrix Drugs of Abuse Whole Blood Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Norbuprenorphine | 10 | ng/mL | n/a |
Codeine | 100 | ng/mL | 25 days |
Fentanyl | 10 | ng/mL | 25 days |
Norfentanyl | 10 | ng/mL | 25 days |
Hydrocodone | 100 | ng/mL | 25 days |
Hydromorphone | 100 | ng/mL | 25 days |
Meperidine | 100 | ng/mL | 25 days |
Methadone | 100 | ng/mL | 25 days |
Methadone Primary Metabolite (EDDP) | 100 | ng/mL | n/a |
Morphine | 100 | ng/mL | 25 days |
Oxycodone | 100 | ng/mL | 25 days |
Oxymorphone | 100 | ng/mL | 25 days |
Tapentadol | 100 | ng/mL | 25 days |
Tramadol | 100 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Acetone | 80 | mg/dL | 30 days |
Ethanol | 150 | mg/dL | 30 days |
Ethylene Glycol | 80 | mg/dL | 30 days |
Isopropanol | 80 | mg/dL | 30 days |
Methanol | 40 | mg/dL | 30 days |
Amphetamines Panel Level 1
Amphetamines Panel 100% Real Human Matrix Urine Drugs of Abuse
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 350 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyamphetamine (MDA) | 350 | ng/mL | 25 days |
d-Methamphetamine | 350 | ng/mL | 25 days |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 350 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 350 | ng/mL | 25 days |
Methylephedrine | 350 | ng/mL | 25 days |
(-)-Ephedrine | 350 | ng/mL | 25 days |
Phendimetrazine | 350 | ng/mL | 25 days |
Phenmetrazine | 350 | ng/mL | 25 days |
Phentermine | 350 | ng/mL | 25 days |
Phenylpropanolamine | 350 | ng/mL | 25 days |
(+)-Pseudoephedrine | 350 | ng/mL | 25 days |
Selegiline | 350 | ng/mL | 25 days |
Amphetamines Panel Level 2
Amphetamines Panel 100% Real Human Matrix Urine Drugs of Abuse
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 700 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyamphetamine (MDA) | 700 | ng/mL | 25 days |
d-Methamphetamine | 700 | ng/mL | 25 days |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 700 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 700 | ng/mL | 25 days |
Methylephedrine | 700 | ng/mL | 25 days |
(-)-Ephedrine | 700 | ng/mL | 25 days |
Phendimetrazine | 700 | ng/mL | 25 days |
Phenmetrazine | 700 | ng/mL | 25 days |
Phentermine | 700 | ng/mL | 25 days |
Phenylpropanolamine | 700 | ng/mL | 25 days |
(+)-Pseudoephedrine | 700 | ng/mL | 25 days |
Selegiline | 700 | ng/mL | 25 days |
Benzodiazepines Plus 100 ng/mL
Benzodiazepines 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Alprazolam | 100 | ng/mL | 25 days |
α-Hydroxyalprazolam | 100 | ng/mL | 25 days |
Chlordiazepoxide | 100 | ng/mL | 25 days |
Norchlordiazepoxide | 100 | ng/mL | 25 days |
Clobazam | 100 | ng/mL | 25 days |
Clonazepam | 100 | ng/mL | 25 days |
7-Aminoclonazepam | 100 | ng/mL | n/a |
Diazepam | 100 | ng/mL | 25 days |
Nordiazepam | 100 | ng/mL | 25 days |
Estazolam | 100 | ng/mL | 25 days |
Flunitrazepam | 100 | ng/mL | 25 days |
7-Aminoflunitrazepam | 100 | ng/mL | n/a |
Flurazepam | 100 | ng/mL | 25 days |
Desalkylflurazepam | 100 | ng/mL | 25 days |
Hydroxyethylflurazepam | 100 | ng/mL | 25 days |
Lorazepam | 100 | ng/mL | 25 days |
Midazolam | 100 | ng/mL | 25 days |
α-Hydroxymidazolam | 100 | ng/mL | 25 days |
Nitrazepam | 100 | ng/mL | 25 days |
7-Aminonitrazepam | 100 | ng/mL | n/a |
Oxazepam | 100 | ng/mL | 25 days |
Temazepam | 100 | ng/mL | 25 days |
Traizolam | 100 | ng/mL | 25 days |
α-Hydroxytriazolam | 100 | ng/mL | 25 days |
Zolpidem | 100 | ng/mL | 25 days |
Benzodiazepines Plus 400 ng/mL
Benzodiazepines 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Alprazolam | 400 | ng/mL | 25 days |
α-Hydroxyalprazolam | 400 | ng/mL | 25 days |
Chlordiazepoxide | 400 | ng/mL | 25 days |
Norchlordiazepoxide | 400 | ng/mL | 25 days |
Clobazam | 400 | ng/mL | 25 days |
7-Aminoclonazepam | 400 | ng/mL | n/a |
Diazepam | 400 | ng/mL | 25 days |
Nordiazepam | 400 | ng/mL | 25 days |
Estazolam | 400 | ng/mL | 25 days |
Flunitrazepam | 400 | ng/mL | 25 days |
7-Aminoflunitrazepam | 400 | ng/mL | n/a |
Flurazepam | 400 | ng/mL | 25 days |
Desalkylflurazepam | 400 | ng/mL | 25 days |
Hydroxyethylflurazepam | 400 | ng/mL | 25 days |
Lorazepam | 400 | ng/mL | 25 days |
Midazolam | 400 | ng/mL | 25 days |
α-Hydroxymidazolam | 400 | ng/mL | 25 days |
Nitrazepam | 400 | ng/mL | 25 days |
7-Aminonitrazepam | 400 | ng/mL | n/a |
Oxazepam | 400 | ng/mL | 25 days |
Temazepam | 400 | ng/mL | 25 days |
Triazolam | 400 | ng/mL | 25 days |
α-Hydroxytriazolam | 400 | ng/mL | 25 days |
Zolpidem | 400 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Methamphetamine | 225 | ng/mL | 25 days |
Benzoylecgonine (BE) | 50 | ng/mL | 25 days |
Methadone | 50 | ng/mL | 25 days |
Methaqualone | 50 | ng/mL | 25 days |
Morphine | 225 | ng/mL | 25 days |
Oxazepam | 50 | ng/mL | 25 days |
Phencyclidine (PCP) | 5 | ng/mL | 25 days |
Propoxyphene | 50 | ng/mL | 25 days |
Secobarbital | 50 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 10 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Methamphetamine | 375 | ng/mL | 25 days |
Benzoylecgonine (BE) | 112.5 | ng/mL | 25 days |
Methadone | 112.5 | ng/mL | 25 days |
Methaqualone | 112.5 | ng/mL | 25 days |
Morphine | 375 | ng/mL | 25 days |
Oxazepam | 75 | ng/mL | 25 days |
Phencyclidine (PCP) | 9.375 | ng/mL | 25 days |
Propoxyphene | 112.5 | ng/mL | 25 days |
Secobarbital | 75 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 15 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Methamphetamine | 750 | ng/mL | 25 days |
Benzoylecgonine | 225 | ng/mL | 25 days |
Methadone | 225 | ng/mL | 25 days |
Methaqualone | 225 | ng/mL | 25 days |
Morphine | 1,500 | ng/mL | 25 days |
Oxazepam | 150 | ng/mL | 25 days |
Phencyclidine (PCP) | 18.75 | ng/mL | 25 days |
Propoxyphene | 225 | ng/mL | 25 days |
Secobarbital | 150 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 37.5 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Methamphetamine | 1,250 | ng/mL | 25 days |
Benzoylecgonine | 375 | ng/mL | 25 days |
Methadone | 375 | ng/mL | 25 days |
Methaqualone | 375 | ng/mL | 25 days |
Morphine | 2,500 | ng/mL | 25 days |
Oxazepam | 250 | ng/mL | 25 days |
Phencyclidine (PCP) | 31.25 | ng/mL | 25 days |
Propoxyphene | 375 | ng/mL | 25 days |
Secobarbital | 250 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 62.5 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Methamphetamine | 1,500 | ng/mL | 25 days |
Benzoylecgonine (BE) | 625 | ng/mL | 25 days |
Methadone | 625 | ng/mL | 25 days |
Methaqualone | 625 | ng/mL | 25 days |
Morphine | 3,000 | ng/mL | 25 days |
Oxazepam | 375 | ng/mL | 25 days |
Phencyclidine (PCP) | 93.75 | ng/mL | 25 days |
Propoxyphene | 625 | ng/mL | 25 days |
Secobarbital | 375 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 125 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
α-Hydroxyalprazolam | 225 | ng/mL | 25 days |
Amobarbital | 225 | ng/mL | 25 days |
d-Amphetamine | 375 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyamphetamine (MDA) | 375 | ng/mL | 25 days |
d-Methamphetamine | 375 | ng/mL | 25 days |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 375 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 375 | ng/mL | 25 days |
Benzoylecgonine (BE) | 112.5 | ng/mL | 25 days |
Butalbital | 225 | ng/mL | 25 days |
Codeine | 1,500 | ng/mL | 25 days |
Nordiazepam | 225 | ng/mL | 25 days |
Hydrocodone | 300 | ng/mL | 25 days |
Hydromorphone | 300 | ng/mL | 25 days |
Lorazepam | 225 | ng/mL | 25 days |
Methadone | 225 | ng/mL | 25 days |
Methadone Primary Metabolite (EDDP) | 225 | ng/mL | 25 days |
Methaqualone | 225 | ng/mL | 25 days |
Morphine-3-β-D-Glucuronide | 2,430 (Equivalent to 1,500 free Morphine) |
ng/mL | 25 days |
6-Monoacetylmorphine (6-MAM) | 7.5 | ng/mL | 25 days |
Nortriptyline | 225 | ng/mL | 25 days |
Oxazepam | 225 | ng/mL | 25 days |
Oxycodone | 225 | ng/mL | 25 days |
Oxymorphone | 225 | ng/mL | 25 days |
Pentobarbital | 225 | ng/mL | 25 days |
Phencyclidine (PCP) | 18.75 | ng/mL | 25 days |
Phenobarbital | 225 | ng/mL | 25 days |
Norpropoxyphene | 225 | ng/mL | 25 days |
Secobarbital | 225 | ng/mL | 25 days |
Temazepam | 225 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 11.25 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
α-Hydroxyalprazolam | 375 | ng/mL | 25 days |
Amobarbital | 375 | ng/mL | 25 days |
d-Amphetamine | 625 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyamphetamine (MDA) | 625 | ng/mL | 25 days |
d-Methamphetamine | 625 | ng/mL | 25 days |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 625 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 625 | ng/mL | 25 days |
Benzoylecgonine (BE) | 187.5 | ng/mL | 25 days |
Butalbital | 375 | ng/mL | 25 days |
Codeine | 2,500 | ng/mL | 25 days |
Nordiazepam | 375 | ng/mL | 25 days |
Hydrocodone (New) | 500 | ng/mL | 25 days |
Hydromorphone (New) | 500 | ng/mL | 25 days |
Lorazepam | 375 | ng/mL | 25 days |
Methadone | 375 | ng/mL | 25 days |
Methadone Primary Metabolite (EDDP) | 375 | ng/mL | 25 days |
Methaqualone | 300 | ng/mL | 25 days |
Morphine-3-β-D-Glucuronide | 4,050 (Equivalent to 2,500 free Morphine) |
ng/mL | 25 days |
6-Monoacetylmorphine (6-MAM) | 12.5 | ng/mL | 25 days |
Nortriptyline | 375 | ng/mL | 25 days |
Oxazepam | 375 | ng/mL | 25 days |
Oxycodone (New) | 375 | ng/mL | 25 days |
Oxymorphone (New) | 375 | ng/mL | 25 days |
Pentobarbital | 375 | ng/mL | 25 days |
Phencyclidine (PCP) | 31.25 | ng/mL | 25 days |
Phenobarbital | 375 | ng/mL | 25 days |
Norpropoxyphene | 375 | ng/mL | 25 days |
Secobarbital | 375 | ng/mL | 25 days |
Temazepam | 375 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 18.75 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
α-Hydroxyalprazolam | 150 | ng/mL | 25 days |
Amobarbital | 150 | ng/mL | 25 days |
d-Amphetamine | 187.5 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyamphetamine (MDA) | 187.5 | ng/mL | 25 days |
d-Methamphetamine | 187.5 | ng/mL | 25 days |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 187.5 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 187.5 | ng/mL | 25 days |
Benzoylecgonine | 75 | ng/mL | 25 days |
Butalbital | 150 | ng/mL | 25 days |
Codeine | 225 | ng/mL | 25 days |
Nordiazepam | 150 | ng/mL | 25 days |
Hydrocodone New | 75 | ng/mL | 25 days |
Hydromorphone New | 75 | ng/mL | 25 days |
Lorazepam | 150 | ng/mL | 25 days |
Methadone | 150 | ng/mL | 25 days |
Methadone Primary Metabolite (EDDP) | 150 | ng/mL | 25 days |
Methaqualone | 150 | ng/mL | 25 days |
Morphine-3-β-D-Glucuronide | 365 (Equivalent to 225 free Morphine) |
ng/mL | 25 days |
6-Monoacetylmorphine (6-MAM) | 7.5 | ng/mL | 25 days |
Nortriptyline | 150 | ng/mL | 25 days |
Oxazepam | 150 | ng/mL | 25 days |
Oxycodone New | 37.5 | ng/mL | 25 days |
Oxymorphone New | 37.5 | ng/mL | 25 daus |
Pentobarbital | 150 | ng/mL | 25 days |
Phencyclidine (PCP) | 18.75 | ng/mL | 25 days |
Phenobarbital | 150 | ng/mL | 25 days |
Norpropoxyphene | 150 | ng/mL | 25 days |
Secobarbital | 150 | ng/mL | 25 days |
Temazepam | 150 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 11.25 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
α-Hydroxyalprazolam | 250 | ng/mL | 25 days |
Amobarbital | 250 | ng/mL | 25 days |
d-Amphetamine | 312.5 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyamphetamine (MDA) | 312.5 | ng/mL | 25 days |
d-Methamphetamine | 312.5 | ng/mL | 25 days |
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 312.5 | ng/mL | 25 days |
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 312.5 | ng/mL | 25 days |
Benzoylecgonine (BE) | 125 | ng/mL | 25 days |
Butalbital | 250 | ng/mL | 25 days |
Codeine | 375 | ng/mL | 25 days |
Nordiazepam | 250 | ng/mL | 25 days |
Lorazepam | 250 | ng/mL | 25 days |
Hydrocodone | 125 | ng/mL | 25 days |
Hydromorphone | 125 | ng/mL | 25 days |
Methadone | 250 | ng/mL | 25 days |
Methadone Primary Metabolite (EDDP) | 250 | ng/mL | 25 days |
Methaqualone | 250 | ng/mL | 25 days |
Morphine-3-β-D-Glucuronide | 608 (Equivalent to 375 free Morphine) |
ng/mL | 25 days |
6-Monoacetylmorphine (6-MAM) | 12.5 | ng/mL | 25 days |
Nortriptyline | 250 | ng/mL | 25 days |
Oxazepam | 250 | ng/mL | 25 days |
Oxycodone | 62.5 | ng/mL | 25 days |
Oxymorphone | 62.5 | ng/mL | 25 days |
Pentobarbital | 250 | ng/mL | 25 days |
Phencyclidine (PCP) | 31.25 | ng/mL | 25 days |
Phenobarbital | 250 | ng/mL | 25 days |
Norpropoxyphene | 250 | ng/mL | 25 days |
Secobarbital | 250 | ng/mL | 25 days |
Temazepam | 250 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 18.75 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Ethyl-β-D-Glucuronide (EtG) | 500 | ng/mL | 20 days |
Ethyl Sulfate (EtS) | 200 | ng/mL | 20 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Ethyl-β-D-Glucuronide (EtG) | 2,000 | ng/mL | 20 days |
Ethyl Sulfate (EtS) | 800 | ng/mL | 20 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
4-ANPP | 5 | ng/mL | 25 |
Acetylfentanyl | 5 | ng/mL | 25 |
Acrylfentanyl | 5 | ng/mL | 25 |
Alfentanil | 5 | ng/mL | 25 |
Butyryl Fentanyl | 5 | ng/mL | 25 |
Carfentanyl | 5 | ng/mL | 25 |
cis-3-Methylfentanyl | 5 | ng/mL | 25 |
Crotonylfentanyl | 5 | ng/mL | 25 |
Fentanyl | 5 | ng/mL | 25 |
Furanyl Fentanyl | 5 | ng/mL | 25 |
Isobutyrylfentanyl | 5 | ng/mL | 25 |
m-Methylmethoxyacetylfentanyl | 5 | ng/mL | 25 |
Methoxyacetylfentanyl | 5 | ng/mL | 25 |
Norfentanyl | 5 | ng/mL | 25 |
Ocfentanyl | 5 | ng/mL | 25 |
ortho-Fluorofentanyl | 5 | ng/mL | 25 |
para-Fluorobutyrylfentanyl | 5 | ng/mL | 25 |
para-Fluoroisobutyrylfentanyl | 5 | ng/mL | 25 |
para-Fluorofentanyl | 5 | ng/mL | 25 |
Sufentanil | 5 | ng/mL | 25 |
Tetrahydrofuran Fentanyl | 5 | ng/mL | 25 |
U-47700 | 5 | ng/mL | 25 |
U-49900 | 5 | ng/mL | 25 |
U51754 | 5 | ng/mL | 25 |
Valerylfentanyl | 5 | ng/mL | 25 |
Cyclopropylfentanyl | 5 | ng/mL | 25 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Carisoprodol | 500 | ng/mL | 25 days |
Cocaine | 100 | ng/mL | 25 days |
Benzoylecgonine | 100 | ng/mL | 25 days |
Cocaethylene | 100 | ng/mL | 25 days |
Cyclobenzaprine | 500 | ng/mL | 25 days |
Meprobamate | 500 | ng/mL | 25 days |
Methaqualone | 100 | ng/mL | 25 days |
Methylphenidate | 500 | ng/mL | 25 days |
Phencyclidine (PCP) | 100 | ng/mL | 25 days |
Ritalinic Acid | 500 | ng/mL | 25 days |
Zolpidem | 200 | ng/mL | 25 days |
(I)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 100 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Carisoprodol | 1,500 | ng/mL | 25 days |
Cocaine | 300 | ng/mL | 25 days |
Benzoylecgonine | 300 | ng/mL | 25 days |
Cocaethylene | 300 | ng/mL | 25 days |
Cyclobenzaprine | 1,500 | ng/mL | 25 days |
Meprobamate | 1,500 | ng/mL | 25 days |
Methaqualone | 300 | ng/mL | 25 days |
Methylphenidate | 1.500 | ng/mL | 25 days |
Phencyclidine (PCP) | 300 | ng/mL | 25 days |
Ritalinic Acid | 1,500 | ng/mL | 25 days |
Zolpidem | 600 | ng/mL | 25 days |
(I)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 300 | ng/mL | 25 days |
Pain Management (PM 100)
100% Real Human Matrix Urine Drugs of Abuse Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Buprenorphine | 100 | ng/mL | 25 days |
Norbuprenorphine | 100 | ng/mL | 25 days |
Codeine | 100 | ng/mL | 30 days |
Fentanyl | 10 | ng/mL | 30 days |
Norfentanyl | 10 | ng/mL | 30 days |
Hydrocodone | 100 | ng/mL | 30 days |
Hydromorphone | 100 | ng/mL | 30 days |
Meperidine | 100 | ng/mL | 30 days |
Methadone | 100 | ng/mL | 30 days |
Methadone Primary Metabolite (EDDP) | 100 | ng/mL | 30 days |
Morphine | 100 | ng/mL | 30 days |
Oxycodone | 100 | ng/mL | 30 days |
Oxymorphone | 100 | ng/mL | 30 days |
Tapentadol | 100 | ng/mL | 25 days |
Tramadol | 100 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Buprenorphine | 50 | ng/mL | 25 days |
Norbuprenorphine | 50 | ng/mL | 25 days |
Codeine | 50 | ng/mL | 25 days |
Norcodeine | 50 | ng/mL | 25 days |
Fentanyl | 5 | ng/mL | 25 days |
Norfentanyl | 5 | ng/mL | 25 days |
Hydrocodone | 50 | ng/mL | 25 days |
Norhydrocodone | 50 | ng/mL | 25 days |
Hydromorphone | 50 | ng/mL | 25 days |
Meperidine | 50 | ng/mL | 25 days |
Normeperidine | 50 | ng/mL | 25 days |
Methadone | 50 | ng/mL | 25 days |
Methadone Primary Metabolite (EDDP) | 50 | ng/mL | 25 days |
Morphine | 50 | ng/mL | 25 days |
6-Monoacetylmorphine (6-MAM) | 5 | ng/mL | 25 days |
Oxycodone | 50 | ng/mL | 25 days |
Noroxycodone | 50 | ng/mL | 25 days |
Oxymorphone | 50 | ng/mL | 25 days |
Noroxymorphone | 50 | ng/mL | 25 days |
Tapentadol | 50 | ng/mL | 25 days |
N-Desmethyltapentadol | 50 | ng/mL | 25 days |
Tramadol | 50 | ng/mL | 25 days |
O-Desmethyl-cis-Tramadol | 50 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Buprenorphine | 400 | ng/mL | 25 days |
Norbuprenorphine | 400 | ng/mL | 25 days |
Codeine | 400 | ng/mL | 25 days |
Norcodeine | 400 | ng/mL | 25 days |
Fentanyl | 40 | ng/mL | 25 days |
Norfentanyl | 40 | ng/mL | 25 days |
Hydrocodone | 400 | ng/mL | 25 days |
Norhydrocodone | 400 | ng/mL | 25 days |
Hydromorphone | 400 | ng/mL | 25 days |
Meperidine | 400 | ng/mL | 25 days |
Normeperidine | 400 | ng/mL | 25 days |
Methadone | 400 | ng/mL | 25 days |
Methadone Primary Metabolite (EDDP) | 400 | ng/mL | 25 days |
Morphine | 400 | ng/mL | 25 days |
6-Monoacetylmorphine (6-MAM) | 40 | ng/mL | 25 days |
Oxycodone | 400 | ng/mL | 25 days |
Noroxycodone | 400 | ng/mL | 25 days |
Oxymorphone | 400 | ng/mL | 25 days |
Noroxymorphone | 400 | ng/mL | 25 days |
Tapentadol | 400 | ng/mL | 25 days |
N-Desmethyltapentadol | 400 | ng/mL | 25 days |
Tramadol | 400 | ng/mL | 25 days |
O-Desmethyl-cis-Tramadol | 400 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Acetaminophen | 5 | µg/mL | 30 days |
d-Amphetamine | 2 | µg/mL | 30 days |
Benzoylecgonine (BE) | 2 | µg/mL | 30 days |
Codeine | 2 | µg/mL | 30 days |
Imipramine | 1 | µg/mL | 30 days |
Methadone | 2 | µg/mL | 30 days |
Methadone Primary Metabolite (EDDP) | 2 | µg/mL | 30 days |
Methaqualone | 2 | µg/mL | 30 days |
Morphine-3-β-D-Glucuronide | 2 | µg/mL | 30 days |
Oxazepam | 2 | µg/mL | 30 days |
Phencyclidine (PCP) | 1 | µg/mL | 30 days |
Phenobarbital | 4 | µg/mL | 30 days |
Propoxyphene | 4 | µg/mL | 30 days |
Quinine | 2 | µg/mL | 30 days |
Secobarbital | 2 | µg/mL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
(±)-Baclofen | 100 | ng/mL | 25 days |
Dextromethorphan (DXM) | 100 | ng/mL | 25 days |
Dextrorphan | 300 | ng/mL | 25 days |
Gabapentin | 2,000 | ng/mL | 25 days |
Ketamine | 200 | ng/mL | 25 days |
Norketamine | 200 | ng/mL | 25 days |
Lamotrigine | 500 | ng/mL | 25 days |
Mitragynine | 25 | ng/mL | N/A |
Naloxone | 100 | ng/mL | 25 days |
Naltrexone | 100 | ng/mL | 25 days |
6-β-Naltrexol | 5 | ng/mL | 25 days |
Pregabalin | 2,000 | ng/mL | 25 days |
Topiramate | 500 | ng/mL | 25 days |
Zaleplon | 5 | ng/mL | 25 days |
Zopiclone | 5 | ng/mL | 25 days |
Zolpidem | 5 | ng/mL | 25 days |
Zolpidem Phenyl-4-Carboxylic Acid | 5 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
(±)-Baclofen | 300 | ng/mL | 25 days |
Dextromethorphan (DXM) | 300 | ng/mL | 25 days |
Dextrorphan | 600 | ng/mL | 25 days |
Gabapentin | 6,000 | ng/mL | 25 days |
Ketamine | 600 | ng/mL | 25 days |
Norketamine | 600 | ng/mL | 25 days |
Lamotrigine | 1,000 | ng/mL | 25 days |
Mitragynine | 250 | ng/mL | N/A |
Naloxone | 300 | ng/mL | 25 days |
Naltrexone | 300 | ng/mL | 25 days |
6-β-Naltrexol | 50 | ng/mL | 25 days |
Pregabalin | 6,000 | ng/mL | 25 days |
Zaleplon | 50 | ng/mL | 25 days |
Zopiclone | 50 | ng/mL | 25 days |
Zolpidem | 50 | ng/mL | 25 days |
Zolpidem Phenyl-4-Carboxylic Acid | 50 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Chromium VI | n/a | µg/mL | n/a |
Creatinine | n/a | mg/dL | n/a |
Nitrites | 500 - 625 | µg/mL | n/a |
Oxidants | n/a | µg/mL | n/a |
pH | 4.5 - 9.0 | n/a | |
Specific Gravity | 1.0010 - 1.0027 | n/a |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Chromium VI | 0 | µg/mL | n/a |
Creatinine | 1.0 - 1.5 | mg/dL | n/a |
Nitrites | 0 | µg/mL | n/a |
Oxidants | 0 | µg/mL | n/a |
pH | 3.2 - 4.0 | n/a | |
Specific Gravity | 1.0210 - 1.0250 | n/a |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Chromium VI | n/a | µg/mL | n/a |
Creatinine | 3.0 - 4.0 | mg/dL | n/a |
Nitrites | 200 - 250 | µg/mL | n/a |
Oxidants | n/a | µg/mL | n/a |
pH | 10.0 - 10.8 | n/a | |
Specific Gravity | 0.9950 - 1.0005 | n/a |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Chromium VI | n/a | µg/mL | n/a |
Creatinine | 21 - 25 | mg/dL | n/a |
Nitrites | n/a | µg/mL | n/a |
Oxidants | n/a | µg/mL | n/a |
pH | 2.0 - 2.8 | n/a | |
Specific Gravity | 1.0040 - 1.0180 | n/a |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Chromium VI | >65 | µg/mL | n/a |
Creatinine | n/a | mg/dL | n/a |
Nitrites | n/a | µg/mL | n/a |
Oxidants | >65 | µg/mL | n/a |
pH | 11.2 - 12.0 | n/a | |
Specific Gravity | n/a | n/a |
Antihypertensives Level 1
Discontinued Products Matrix 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Amlodipine | 10 | ng/mL | 25 |
Atenolol | 100 | ng/mL | 25 |
Clonidine | 5 | ng/mL | 25 |
Furosemide | 200 | ng/mL | 25 |
Hydrochlorothiazide | 50 | ng/mL | 25 |
Metoprolol | 100 | ng/mL | 25 |
Propranolol | 10 | ng/mL | 25 |
Antihypertensives Level 2
Discontinued Products 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Amlodipine | 100 | ng/mL | 25 |
Atenolol | 600 | ng/mL | 25 |
Clonidine | 50 | ng/mL | 25 |
Furosemide | 800 | ng/mL | 25 |
Hydrochlorothiazide | 300 | ng/mL | 25 |
Metoprolol | 500 | ng/mL | 25 |
Propranolol | 1,000 | ng/mL | 25 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Apixaban | 30 | ng/mL | 25 |
Dabigartran | 30 | ng/mL | 25 |
Rivaroxaban | 20 | ng/mL | 25 |
Salicylic Acid | 80 | µg/mL | 25 |
Warfarin | 3 | µg/mL | 25 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Apixaban | 350 | ng/mL | 25 |
Dabigartran | 350 | ng/mL | 25 |
Rivaroxaban | 300 | ng/mL | 25 |
Salicylic Acid | 400 | µg/mL | 25 |
Warfarin | 10 | µg/mL | 25 |
Busulfan Level 1
Plasma Discontinued Products 100% Real Human Matrix Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Busulfan | 350 | ng/mL | 25 Days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Busulfan | 3500 | ng/mL | 25 Days |
Mid Range Clonazepam
Benzodiazepines 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Clonazepam | 50 | ng/mL | 30 days |
High Range Clonazepam
Benzodiazepines 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Clonazepam | 100 | ng/mL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Mycophenolic Acid (MPA) | 2 | µg/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Mycophenolic Acid (MPA) | 7.5 | µg/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Estazolam | 30 | ng/mL | 25 |
Temazepam | 100 | ng/mL | 25 |
Triazolam | 10 | ng/mL | 25 |
Eszopiclone | 10 | ng/mL | 25 |
Ramelteon | 10 | ng/mL | 25 |
Suvorexant | 100 | ng/mL | 25 |
Zaleplon | 10 | ng/mL | 25 |
Zolpidem | 10 | ng/mL | 25 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Estazolam | 150 | ng/mL | 25 |
Temazepam | 1,500 | ng/mL | 25 |
Triazolam | 100 | ng/mL | 25 |
Eszopiclone | 100 | ng/mL | 25 |
Ramelteon | 100 | ng/mL | 25 |
Suvorexant | 600 | ng/mL | 25 |
Zaleplon | 100 | ng/mL | 25 |
Zolpidem | 100 | ng/mL | 25 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Androstenedione | 0 | ng/mL | 25 days |
Hydrocortisone (Cortisol) | 0 | µg/dL | 25 days |
Cortisone | 0 | µg/dL | 25 days |
Corticosterone | 0 | ng/dL | 25 days |
11-Deoxycortisol | 0 | ng/dL | 25 days |
Dehydroepiandrosterone (DHEA) | 0 | ng/mL | 25 days |
Progesterone | 0 | ng/mL | 25 days |
17α-Hydroxyprogesterone | 0 | µg/dL | 25 days |
Testosterone | 0 | ng/dL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
(-)-Delta-9-THC | 2.5 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC | 25 | ng/mL | 25 days |
(±)-11-Hydroxy-Delta-9-THC | 2.5 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
(-)-Delta-9-THC | 25 | ng/mL | 25 days |
(l)-9-Carboxy-11-nor-Delta-9-THC | 250 | ng/mL | 25 days |
(±)-11-Hydroxy-Delta-9-THC | 25 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 0 | ng/mL | 30 days |
d-Methamphetamine | 0 | ng/mL | 30 days |
Benzoylecgonine (BE) | 0 | ng/mL | 30 days |
Methadone | 0 | ng/mL | 30 days |
Morphine | 0 | ng/mL | 30 days |
Oxazepam | 0 | ng/mL | 30 days |
Phencyclidine (PCP) | 0 | ng/mL | 30 days |
Propoxyphene | 0 | ng/mL | 30 days |
Secobarbital | 0 | ng/mL | 30 days |
Delta-9-THC | 0 | ng/mL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 12.5 | ng/mL | 25 |
d-Methamphetamine | 12.5 | ng/mL | 25 |
Benzoylecgonine | 7.5 | ng/mL | 25 |
Methadone | 25 | ng/mL | 25 |
Morphine | 15 | ng/mL | 25 |
Oxazepam | 25 | ng/mL | 25 |
Oxycodone | 15 | ng/mL | 25 |
Phencyclidine (PCP) | 1.5 | ng/mL | 25 |
Delta-9-THC | 2 | ng/mL | 14 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 50 | ng/mL | 25 |
d-Methamphetamine | 50 | ng/mL | 25 |
Benzoylecgonine | 30 | ng/mL | 25 |
Methadone | 100 | ng/mL | 25 |
Morphine | 60 | ng/mL | 25 |
Oxazepam | 100 | ng/mL | 25 |
Oxycodone | 60 | ng/mL | 25 |
Phencyclidine (PCP) | 6 | ng/mL | 25 |
Delta-9-THC | 8 | ng/mL | 14 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Benzoylecgonine | 0 | ng/mL | 14 |
(-)-Cotinine | 0 | ng/mL | 14 |
Caffeine | 0 | ng/mL | 14 |
d-Amphetamine | 0 | ng/mL | 14 |
d-Methamphetamine | 0 | ng/mL | 14 |
Ethanol | 0 | ng/mL | 14 |
Methadone | 0 | ng/mL | 14 |
Morphine | 0 | ng/mL | 14 |
Oxazepam | 0 | ng/mL | 14 |
Oxycodone | 0 | ng/mL | 14 |
Phencyclidine (PCP) | 0 | ng/mL | 14 |
Secobarbital | 0 | ng/mL | 14 |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC COOH) |
0 | ng/mL | 14 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Benzoylecgonine | 10 | ng/mL | 14 |
(-)-Cotinine | 2.5 | ng/mL | 14 |
Caffeine | 10 | ng/mL | 14 |
d-Amphetamine | 10 | ng/mL | 14 |
Ethanol | 5 | ng/mL | 14 |
Methadone | 12.5 | ng/mL | 14 |
Morphine | 10 | ng/mL | 14 |
Oxazepam | 50 | ng/mL | 14 |
Oxycodone | 5 | ng/mL | 14 |
Phencyclidine (PCP) | 5 | ng/mL | 14 |
Secobarbital | 40 | ng/mL | 14 |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) |
5 | ng/mL | 14 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Benzoylecgonine | 20 | ng/mL | 14 |
(-)-Cotinine | 5 | ng/mL | 14 |
Caffeine | 500 | ng/mL | 14 |
d-Amphetamine | 20 | ng/mL | 14 |
d-Methamphetamine | 20 | ng/mL | 14 |
Ethanol | 10 | ng/mL | 14 |
Methadone | 25 | ng/mL | 14 |
Oxazepam | 100 | ng/mL | 14 |
Oxycodone | 10 | ng/mL | 14 |
Phencyclidine (PCP) | 10 | ng/mL | 14 |
Secobarbital | 40 | ng/mL | 14 |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) |
10 | ng/mL | 14 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Benzoylecgonine | 40 | ng/mL | 14 |
(-)-Cotinine | 10 | ng/mL | 14 |
Caffeine | 1,000 | ng/mL | 14 |
d-Amphetamine | 40 | ng/mL | 14 |
d-Methamphetamine | 40 | ng/mL | 14 |
Ethanol | 10 | ng/mL | 14 |
Methadone | 50 | ng/mL | 14 |
Morphine | 40 | ng/mL | 14 |
Oxazepam | 200 | ng/mL | 14 |
Oxycodone | 20 | ng/mL | 14 |
Phencyclidine (PCP) | 20 | ng/mL | 14 |
Secobarbital | 80 | ng/mL | 14 |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) |
20 | ng/mL | 14 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cannabigerol (CBG) | 5 | ng/mL | 14 days |
Cannabinol (CBN) | 5 | ng/mL | 14 days |
(-)-Delta-9-THC | 5 | ng/mL | 14 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 10 | ng/mL | 14 days |
(±)-11-Hydroxy-Delta-9-THC | 5 | ng/mL | 14 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cannabigerol | 50 | ng/mL | 14 days |
Cannabinol | 50 | ng/mL | 14 days |
(-)-Delta-9-THC | 50 | ng/mL | 14 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 100 | ng/mL | 14 days |
(±)-11-Hydroxy-Delta-9-THC | 50 | ng/mL | 14 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cannabigerol (CBG) | 100 | ng/mL | 14 days |
Cannabinol (CBN) | 100 | ng/mL | 14 days |
(-)-Delta-9-THC | 100 | ng/mL | 14 days |
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 200 | ng/mL | 14 days |
(±)-11-Hydroxy-Delta-9-THC | 100 | ng/mL | 14 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Ethanol | 100 200 300 |
mg/dL | 30 days |
Immunosuppressants (6mL) Level 1
Immunosuppressants 100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cyclosporine | 90 | ng/mL | 30 days |
Everolimus | 4 | ng/mL | 25 days |
Sirolimus | 4 | ng/mL | 25 days |
Tacrolimus | 4 | ng/mL | 25 days |
Immunosuppressants Level 2 (6mL)
100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cyclosporine | 500 | ng/mL | 30 days |
Everolimus | 15 | ng/mL | 25 days |
Sirolimus | 15 | ng/mL | 25 days |
Tacrolimus | 15 | ng/mL | 25 days |
Immunosuppressants Level 3 (6mL)
100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Cyclosporine | 1,200 | ng/mL | 30 days |
Everolimus | 25 | ng/mL | 25 days |
Sirolimus | 25 | ng/mL | 25 days |
Tacrolimus | 25 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 10 | ng/mL | 25 |
Gamma-Hydroxybutyric Acid (GHB) | 10 | µg/mL | 25 |
Flunitrazepam | 10 | ng/mL | 25 |
Ketamine | 50 | ng/mL | 25 |
Zaleplon | 10 | ng/mL | 25 |
Zolpidem | 10 | ng/mL | 25 |
Zopiclone | 10 | ng/mL | 25 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 100 | ng/mL | 25 |
Gamma-Hydroxybutryic Acid (GHB) | 40 | µg/mL | 25 |
Flunitrazepam | 100 | ng/mL | 25 |
Ketamine | 200 | ng/mL | 25 |
Zaleplon | 100 | ng/mL | 25 |
Zolpidem | 100 | ng/mL | 25 |
Zopiclone | 100 | ng/mL | 25 |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Butylone | 15 | ng/mL | 14 days |
Ethylone | 15 | ng/mL | 14 days |
Mephedrone | 15 | ng/mL | 14 days |
*Methedrone | 15 | ng/mL | 14 days |
Methylone | 15 | ng/mL | 14 days |
3,4-Methylenedioxypyrovalerone (MDPV) | 15 | ng/mL | 14 days |
α-Pyrrolidinovalerophenone (α-PVP) | 15 | ng/mL | 14 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Amobarbital | 1,500 | ng/mL | 25 days |
Butabarbital | 1,500 | ng/mL | 25 days |
Butalbital | 1,500 | ng/mL | 25 days |
Pentobarbital | 1,500 | ng/mL | 25 days |
Phenobarbital | 1,500 | ng/mL | 25 days |
Secobarbital | 1,500 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
d-Amphetamine | 0 | ng/mL | 30 days |
d-Methamphetamine | 0 | ng/mL | 30 days |
Benzoylecgonine (BE) | 0 | ng/mL | 30 days |
Morphine | 0 | ng/mL | 30 days |
Oxazepam | 0 | ng/mL | 30 days |
(l)-9-Carboxy-11-nor-Delta-9-THC | 0 | ng/mL | 30 days |
Other* | 0 | ng/mL | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 100 | ng/mL | 25 days |
Dextromethorphan (DXM) | 50 | ng/mL | 25 days |
Dimethyltryptamine (DMT) | 50 | ng/mL | 25 days |
Ketamine | 50 | ng/mL | 25 days |
Lysergic Acid Diethylamide (LSD) | 5 | ng/mL | 25 days |
Mescaline | 50 | ng/mL | 25 days |
Mitragynine | 50 | ng/mL | 25 days |
Phencyclidine (PCP) | 10 | ng/mL | 25 days |
Psilocybin | 50 | ng/mL | 25 days |
Salvinorin A | 5 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
(±)-3,4-Methylenedioxymethamphetamine (MDMA) | 300 | ng/mL | 25 days |
Dextromethorphan (DXM) | 200 | ng/mL | 25 days |
Dimethyltryptamine (DMT) | 200 | ng/mL | 25 days |
Ketamine | 200 | ng/mL | 25 days |
Lysergic Acid (LSD) | 20 | ng/mL | 25 days |
Mescaline | 200 | ng/mL | 25 days |
Mitragynine | 200 | ng/mL | 25 days |
Phencyclidine (PCP) | 100 | ng/mL | 25 days |
Psilocybin | 200 | ng/mL | 25 days |
Salvinorin A | 20 | ng/mL | 25 days |
Nicotine Plus Level 1
Discontinued Products 100% Real Human Matrix Urine Nicotine / Alkaloids
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Nicotine | 100 | ng/mL | 20 days |
Anabasine | 100 | ng/mL | 20 days |
(-)-Cotinine | 100 | ng/mL | 20 days |
trans-3-Hydroxy Cotinine | 100 | ng/mL | 20 days |
Nornicotine | 100 | ng/mL | 20 days |
Nicotine Plus Level 2
Discontinued Products 100% Real Human Matrix Urine Nicotine / Alkaloids
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Nicotine | 1,000 | ng/mL | 20 days |
Anabasine | 1,000 | ng/mL | 20 days |
(-)-Cotinine | 1,000 | ng/mL | 20 days |
trans-3-Hydroxy Cotinine | 1,000 | ng/mL | 20 days |
Nornicotine | 1,000 | ng/mL | 20 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Creatinine | 21 - 35 | mg/dL | 30 days |
Specific Gravity | >1.003 | ng/mL | 30 days |
pH | 2 - 3 | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Creatinine | 21 - 35 | mg/dL | 30 days |
Specific Gravity | >1.003 | ng/mL | 30 days |
pH | 11 - 12 | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
AM2201 N-(4-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
JWH 018 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
JWH 073 N-(4-Hydroxybutyl) Metabolite | 15 | ng/mL | 14 days |
JWH 081 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
JWH 122 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
JWH 210 N-(5-Carboxypentyl) Metabolite | 15 | ng/mL | 14 days |
JWH 250 4-Hydroxypentyl Metabolite | 15 | ng/mL | 14 days |
MAM2201 N-Pentanoic Acid Metabolite | 15 | ng/mL | 14 days |
RCS-4 M9 Metabolite | 15 | ng/mL | 14 days |
RCS-4 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
UR-144 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
XLR11 N-(4-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
AM2201 N-(4-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
JWH 018 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
JWH 073 N-(4-Hydroxybutyl) Metabolite | 150 | ng/mL | 14 days |
**JWH 081 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
JWH 122 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
JWH 210 N-(5-Carboxypentyl) Metabolite | 150 | ng/mL | 14 days |
JWH 250 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
MAM2201 N-Pentanoic Acid Metabolite | 150 | ng/mL | 14 days |
RCS-4 M9 Metabolite | 150 | ng/mL | 14 days |
RCS-4 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
UR-144 5-Hydroxypentyl Metabolite | 150 | ng/mL | 14 days |
XLR11 N-(4-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Bupropion | 100 | ng/mL | 25 days |
Hydroxybupropion | 150 | ng/mL | 25 days |
Citalopram | 100 | ng/mL | 25 days |
N-Desmethylcitalopram | 100 | ng/mL | 25 days |
Duloxetine | 100 | ng/mL | 25 days |
Fluvoxamine | 100 | ng/mL | 25 days |
Nefazodone | 300 | ng/mL | 25 days |
Paroxetine | 100 | ng/mL | 25 days |
Sertraline | 100 | ng/mL | 25 days |
Desmethylsertraline | 100 | ng/mL | 25 days |
Venlafaxine | 100 | ng/mL | 25 days |
O-Desmethylvenlafaxine | 100 | ng/mL | 25 days |
SSRI 12 Level 2
Discontinued Products 100% Real Human Matrix Urine SSRI Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Bupropion | 600 | ng/mL | 25 days |
Hydroxybupropion | 900 | ng/mL | 25 days |
Citalopram | 300 | ng/mL | 25 days |
N-Desmethylcitalopram | 300 | ng/mL | 25 days |
Duloxetine | 500 | ng/mL | 25 days |
Fluvoxamine | 900 | ng/mL | 25 days |
Nefazodone | 900 | ng/mL | 25 days |
Paroxetine | 500 | ng/mL | 25 days |
Sertraline | 300 | ng/mL | 25 days |
Desmethylsertraline | 300 | ng/mL | 25 days |
Venlafaxine | 500 | ng/mL | 25 days |
O-Desmethylvenlafaxine | 500 | ng/mL | 25 days |
TCA Panel Level 1
Discontinued Products 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Amitriptyline | 150 | ng/mL | 25 days |
Amoxapine | 150 | ng/mL | 25 days |
Clomipramine | 150 | ng/mL | 25 days |
Desmethylclomipramine | 150 | ng/mL | 25 days |
Doxepin | 150 | ng/mL | 25 days |
Desmethyldoxepin | 150 | ng/mL | 25 days |
Fluoxetine | 150 | ng/mL | 25 days |
Norfluoxetine | 150 | ng/mL | 25 days |
Imipramine | 150 | ng/mL | 25 days |
Desipramine | 150 | ng/mL | 25 days |
Maprotiline | 150 | ng/mL | 25 days |
Mirtazapine | 150 | ng/mL | 25 days |
Nortriptyline | 150 | ng/mL | 25 days |
Protriptyline | 150 | ng/mL | 25 days |
Trazodone | 300 | ng/mL | 25 days |
Trimipramine | 150 | ng/mL | 25 days |
Desmethyltrimipramine | 150 | ng/mL | 25 days |
TCA Panel Level 2
Discontinued Products 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Amitriptyline | 400 | ng/mL | 25 days |
Amoxapine | 400 | ng/mL | 25 days |
Clomipramine | 400 | ng/mL | 25 days |
Desmethylclomipramine | 400 | ng/mL | 25 days |
Doxepin | 400 | ng/mL | 25 days |
Desmethyldoxepin | 400 | ng/mL | 25 days |
Fluoxetine | 400 | ng/mL | 25 days |
Norfluoxetine | 400 | ng/mL | 25 days |
Imipramine | 400 | ng/mL | 25 days |
Desipramine | 400 | ng/mL | 25 days |
Maprotiline | 400 | ng/mL | 25 days |
Mirtazapine | 400 | ng/mL | 25 days |
Nortriptyline | 400 | ng/mL | 25 days |
Protriptyline | 400 | ng/mL | 25 days |
Trazodone | 800 | ng/mL | 25 days |
Trimipramine | 400 | ng/mL | 25 days |
Desmethyltrimipramine | 400 | ng/mL | 25 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Creatinine | <5 | mg/dL | 30 days |
Specific Gravity | ≤1.001 | 30 days | |
Nitrites | Negative | µg/mL | 30 days |
pH | 6 - 7 | 30 days |
Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Creatinine | 10 - 19 | mg/dL | 30 days |
Specific Gravity | ≤1.003 | 30 days | |
Nitrites | 400 | ng/mL | 30 days |
pH | 6 - 7 | 30 days |
High Range Validity Check
Discontinued Products 100% Real Human Matrix Urine Urinary Modifier
Learn MoreAnalyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
---|---|---|---|
Creatinine | 21 - 35 | mg/dL | 30 days |
Specific Gravity | >1.003 | 30 days | |
Nitrites | 600 | ng/mL | 30 days |
pH | 6 - 7 | 30 days |